Watch Ticker

BioCryst Pharmaceuticals Inc

Go to BioCryst Pharmaceuticals Inc Website

$8.36

0.00 (0.00%)

Live

Previous Close

$8.36

Day Range

$0 - $0

Previous Day Range

$8.33 - $8.69

Market Cap

$1.8 billion USD

Day Vol.

Previous Day Vol.

4.2 million

Currency

USD

Primary Exchange

Nasdaq

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple sci...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Jesterai - BioCryst (BCRX) Q2 Revenue Jumps 50%

BioCryst Pharmaceuticals reported record Q2 2025 revenue of $163.4 million, achieving its first significant GAAP net profit. ORLADEYO prescription drug sales grew 45% year-over-year, driving strong financial performance and positioning the company for continued growth in rare disease treatments.

Related tickers: BCRX.

Read Full Article

Biocryst Pharmaceuticals - BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December

BioCryst Pharmaceuticals announced that Charlie Gayer will succeed Jon Stonehouse as CEO, effective January 1, 2026, after a successful commercial launch of ORLADEYO and driving significant revenue growth.

Related tickers: BCRX, GIKLY.

Read Full Article

Trending Tickers

Please sign in to view